Burroughs Amy L. (CIK 1872564) reported 18 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-17). Recent activity: Buy TERN (14,583 shares), Sell TERN (11,813 shares), Sell TERN (2,770 shares), Buy TERN (14,583 shares), Sell TERN (2,341 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-17 | Terns Pharmaceuticals, Inc. (TERN) | Chief Executive Officer | Buy | 14,583 | $67,665 |
| 2026-03-17 | Terns Pharmaceuticals, Inc. (TERN) | Chief Executive Officer | Sell | 11,813 | $550,131 |
| 2026-03-17 | Terns Pharmaceuticals, Inc. (TERN) | Chief Executive Officer | Sell | 2,770 | $131,021 |
| 2026-02-18 | Terns Pharmaceuticals, Inc. (TERN) | Chief Executive Officer | Buy | 14,583 | $67,665 |
| 2026-02-18 | Terns Pharmaceuticals, Inc. (TERN) | Chief Executive Officer | Sell | 2,341 | $89,122 |
| 2026-02-18 | Terns Pharmaceuticals, Inc. (TERN) | Chief Executive Officer | Sell | 8,159 | $319,996 |
| 2026-02-18 | Terns Pharmaceuticals, Inc. (TERN) | Chief Executive Officer | Sell | 4,083 | $162,503 |
| 2026-01-16 | Terns Pharmaceuticals, Inc. (TERN) | Chief Executive Officer | Buy | 150,000 | $0 |
| 2026-01-16 | Terns Pharmaceuticals, Inc. (TERN) | Chief Executive Officer | Buy | 27,083 | $125,665 |
| 2026-01-16 | Terns Pharmaceuticals, Inc. (TERN) | Chief Executive Officer | Buy | 27,083 | $125,665 |
| 2026-01-16 | Terns Pharmaceuticals, Inc. (TERN) | Chief Executive Officer | Buy | 14,583 | $67,665 |
| 2026-01-16 | Terns Pharmaceuticals, Inc. (TERN) | Chief Executive Officer | Sell | 61,228 | $2.3M |
| 2026-01-16 | Terns Pharmaceuticals, Inc. (TERN) | Chief Executive Officer | Sell | 7,521 | $282,263 |
| 2026-01-06 | Terns Pharmaceuticals, Inc. (TERN) | Chief Executive Officer | Buy | 21,551 | $99,997 |
| 2026-01-06 | Terns Pharmaceuticals, Inc. (TERN) | Chief Executive Officer | Buy | 150,000 | $0 |
| 2026-01-06 | Terns Pharmaceuticals, Inc. (TERN) | Chief Executive Officer | Sell | 71,339 | $2.7M |
| 2025-06-25 | Terns Pharmaceuticals, Inc. (TERN) | Chief Executive Officer | Buy | 23,314 | $90,225 |
| 2025-02-03 | Terns Pharmaceuticals, Inc. (TERN) | Chief Executive Officer | Buy | 510 | $2,606 |
Source: SEC Form 4 filings · as of 2026-03-17